Adrenomedullin 2 (ADM2), also referred to as intermedin (IMD), is expressed in trophoblast cells in human placenta and enhances the invasion and migration of first-trimester HTR-8SV/ neo cells. Further infusion of ADM2 antagonist in pregnant rat causes fetoplacental growth restriction, suggesting a role for ADM2 in maintaining a successful pregnancy. This study was undertaken to assess whether ADM2 protein is present in decidual tissue and colocalized with HLA-G-positive cytotrophoblast cells and natural killer cells; to assess whether ADM2 regulates expression of HLA-G in trophoblast cells; and to identify whether mitogen-activated protein kinase (MAPK) signaling pathway is involved in ADM2-induced trophoblast cell invasion and migration. Using immunohistochemical methods and RT-PCR, this study shows that ADM2 protein is colocalized with HLA-G-expressing cytotrophoblast cells as well as with NCAM1 (CD56) immunoreactivity in human first-trimester decidual tissue, and that ADM2 mRNA is expressed in peripheral blood natural killer cells. Further, ADM2 dose dependently increases the expression of HLA-G antigen in HTR-8SV/neo cells as well as in term placental villi explants, suggesting involvement of ADM2 in the regulation of HLA-G in trophoblast cells. In addition, interference with the activity of RAF and MAPK3/1 by their inhibitors, manumycin and U0126, respectively, reduces ADM2-induced HTR-8SV/neo cell invasion and migration. In summary, this study suggests a potential involvement for ADM2 in regulating HLA-G antigen at the maternal-fetal interface in human pregnancy and facilitating trophoblast invasion and migration via MAPK3/1 phosphorylation.
INTRODUCTION
Adrenomedullin 2 (ADM2), also referred to as intermedin (IMD), is a 47-amino acid peptide that belongs to the calcitonin gene-related peptide (CALCA/CALCB) family. ADM2 has ;28% structural homology to adrenomedullin (ADM) and ,20% to CALCB. ADM2 is abundantly expressed in rat ovary, uterus, and placenta, along with its expression in other tissues, such as brain, heart, and pituitary gland. Recently we reported that plasma levels of immunoreactive ADM2 are elevated during pregnancy and that ADM2-induced vasodilation is greater during pregnancy in rats [1] . Blocking of endogenous effects of ADM2 in pregnant rat by infusion of ADM2 antagonist (ADM2 ) , causes fetoplacental growth restriction [2] . In addition, we reported that ADM2 is expressed in human placenta at all stages of pregnancy, and it increases the invasive and migratory capacity of immortalized firsttrimester human trophoblast (HTR-8SV/neo) cells [3] . Cytotrophoblasts play a central role in the development and maintenance of a successful pregnancy. In humans, trophoblasts differentiate from cytotrophoblast stem cells along two pathways. Villous trophoblasts fuse to form a syncytium and are bathed in maternal blood, whereas extravillous trophoblasts (EVTs) invade the decidua. The EVTs migrate from the anchoring villi to form two subpopulations. The interstitial EVTs invade the uterine wall, whereas the endovascular EVTs migrate along the lumen of the spiral artery retrograde to blood flow as far as the myometrial segment [4] . Insufficient EVT invasion and artery remodeling are associated with the development of preeclampsia, intrauterine growth restriction, and placental abruption; however, the exact etiology of these disorders is not fully understood [5] [6] [7] . Nonclassical major histocompatibility complex class I HLA-G gene, expressed exclusively in extravillous cytotrophoblast migrating into the uterine tissue [8] , is suggested to play a role in immune tolerance to facilitate the semiallogenic pregnancy by either direct interaction with killing inhibitory receptors found on natural killer (NK) and T-cell subsets, including killer immunoglobulinlike (Ig-like) receptor protein, KIR2DL4, and Ig-like transcript-2 (ILT-2) [9] [10] [11] [12] expressed by NK cells, or by an indirect mechanism involving the HLA-E molecule [13] . Interaction of HLA-G with its receptors causes cytotoxic T lymphocytes to either die or reduce production of their activator cell surface molecule, CD8, immobilizing NK cells and programming mononuclear phagocytes into suppressive modes [14] . The regulatory mechanisms that control restricted HLA-G gene expression are unknown. However, transcriptional mechanisms are likely to play an important role, because most cell types that do not express HLA-G surface protein exhibit basal or null HLA-G transcriptional activity. Extravillous cytotrophoblast cells HTR-8SV/neo and JEG-3 choriocarcinoma are HLA-G-expressing trophoblast cells that exhibit high levels of HLA-G transcripts [15, 16] . HLA-G is important in the events occurring in the uteroplacental environment in early pregnancy by not only regulating interactions with maternal immune cells and endothelial cells, but also in the regulation of trophoblast migration.
Although we have recently reported that ADM2 is expressed in HTR-8SV/neo cells and provided evidence for a potential role for ADM2 in trophoblast invasion and migration in human pregnancy [3] , molecular mechanisms that mediate ADM2 effects are not known. It is not known whether activation of mitogen-activated protein kinase (MAPK) signaling, which is reported earlier in trophoblast migration, mediates AMD2-induced invasion and migration of trophoblast cells. HLA-G is expressed by both endovascular and interstitial EVTs, and its expression increases as they migrate towards the vasculature [17] . Because ADM2 is expressed in cytotrophoblast cells and increases trophoblast migration, this study was undertaken to assess whether ADM2 is localized in HLA-Gexpressing invaded cytotrophoblast cells as well as NK cells in human decidual tissue and in peripheral blood NK (pNK) cells, which are known to be the critical components of innate and adaptive immunity. In addition, we assessed whether ADM2 is involved in the regulation of HLA-G antigen in the trophoblast cells. MAPK pathways are known to be involved in various cellular processes, including cell migration, growth, differentiation, and cell death [18] [19] [20] . Activation of RAS stimulates the protein kinase activity of RAF kinase and RAF kinase phosphorylates, and activates MAP2K1 (MEK). MAP2K1 than phosphorylates and activates a MAPK [21] . Therefore, in this study we assessed whether activation of RAF/MAP2K1/ MAPK3/1 signaling pathway is involved in ADM2-induced HTR cell migration. This study suggests a potential involvement of ADM2 in decidual autocrine/paracrine networks that regulate HLA-G and trophoblast invasion and migration at the maternal-fetal interface in human pregnancy.
MATERIALS AND METHODS
All human participants were patients admitted to the University of Texas Medical Branch (UTMB). Decidual tissue and blood was collected for women undergoing elective abortion at 6-10 wk of pregnancy. Third-trimester placentas were collected from women who delivered full-term normal babies. Written informed consent was obtained from each woman prior to surgery using consent forms and protocols approved by the Institutional Review Board of UTMB Committee. Villous tissues from third-trimester placentas were washed with PBS and carefully dissected to exclude any decidual tissue and membrane contamination. Decidual tissue was washed with PBS and carefully dissected to remove placental membranes and villous material as described in a previous report [22] . Decidual tissue was then embedded in optimal cutting temperature (OCT) medium and flash frozen. For immunohistochemical studies, tissues were cut at 5-to 7-lm thicknesses and mounted on gelatincoated slides.
HTR-8SV/neo Cell Culture
The HTR-8SV/neo cells were a gift provided by Dr. Charles H. Graham (Queen's University, Kingston, ON). This cell line was established from explant culture of first-trimester human placenta and immortalized by the simian virus 40 large T antigen [23] . These cells exhibit a high proliferation index and share various phenotypic similarities with the parental HTR-8SV/neo cells, including in vitro invasive abilities. Cells (6 3 10 5 per well in six-well plates) were plated for 6 h in 1 ml of RPMI 1640 and 10% fetal bovine serum (FBS), cultured overnight, and subsequently incubated in fresh media containing 1.5% FBS for 2 h before being treated with ADM2 (10 À9 M to 10 À7 M) in the presence or absence of ADM2 antagonist (ADM2 17-47 ; 10 À5 M). Cells were harvested after 24 h for extraction of total RNA.
Placental Explant Culture
Placental explant culture system was developed as per the published procedures [24] . Separate areas of each placenta were sampled within 30 min of delivery. Chorionic villi were dissected from these areas and carefully rinsed in sterile PBS at 378C. The tissue was then cut into small pieces. For each treatment, 50-60 mg wet weight of tissue was cultured in 24-well plates in 1 ml of culture medium (RPMI þ 2% FBS) for 2 h. The cultures were then treated with ADM2 (10 À9 M to 10 À7 M) in the presence or absence of the antagonist ADM2 (10 À5 M) for 24 h and processed for extraction of total RNA and protein extraction.
Immunofluorescent Confocal Imaging Analysis
The OCT-embedded frozen decidual tissue sections were fixed with methanol and acetone mixture (1:1) for 15 min, and washed twice for 5 min in PBS containing Tween-20 (PBS-T) washing solution. To block endogenous peroxidases, samples were incubated in 0.1% H 2 O 2 in PBS for 20 min at room temperature followed by blocking for 60 min with serum blocking solution (10% normal goat serum and 1% bovine serum albumin in PBS). The slides were then treated with Image-It Enhancer (Molecular Probes, Eugene, OR). The first primary antibody, rabbit anti-ADM2 antibody (Alpha Diagnostics, San Antonio, TX) was applied at a 1:100 dilution followed by donkey anti-rabbit IgG Alexa 488. For double immunostaining, the slides stained with first primary antibody were thoroughly rinsed with Tween/PBS followed by the application of the second primary (monoclonal) antibody anti-NCAM1 antibody (Dako, Carpinteria, CA), CK-7 (Dako), or HLA-G (Santa Cruz Biotechnology, Santa Cruz, CA) at a 1:150 dilution for 60 min. Mouse IgG1 (Dako) was applied as a negative control. Chicken anti-mouse IgG-Alexa Fluor 594 (Molecular Probes) was used for detection of the first primary antibody. Absence of antibody, preimmune serum, or mouse IgG Ready to Use (Dako) was used as negative control. ADM2 antibody neutralized by ADM2 peptide and secondary antibody alone were also used as negative controls (data not shown). Slides were then counterstained with 4 0 ,6-diamidino-2-phenylindole (DAPI; Vector Laboratories Inc., Burlingame, CA) after treatment with Autofluorescence Eliminator Reagent (Chemicon International, Temecula, CA) and viewed under an Olympus BX51 microscope, and images were recorded by a DP70 Digital Camera (Olympus Optical Co. Ltd., Tokyo, Japan).
Protein Extraction
Placental explants were homogenized in ice-cold lysis buffer (50 mM TrisHCl, 120 mM NaCl, 0.4% Nonidet P-40, 100 mM NaF, 200 mM NaVO 5 , 1 mM phenylmethylsulfonyl fluoride, 10 lg/ml leupeptin, and 10 lg/ml aprotinin). Extracted total protein concentration was estimated by bicinchoninic acid method and used for Western blot analysis.
Isolation of Total RNA and RT
Total RNA was isolated from normal-term placental tissue and from HTR-8SV/neo and U936 cells using TRIzol (Life Technologies, Grand Island, NY). RNA extraction was followed by DNase 1 (Ambion, Austin, TX) treatment to remove DNA contamination. The quality and quantity of the RNA were assessed at absorbance 260 and 280 nm, and all samples showed absorbency ratios ranging between 1.8 and 2.0. For RT, 2 lg of total RNA was mixed with 
Polymerase Chain Reaction
The PCR of the cDNA was initiated by the published primers for human HLA-G and ADM2. The primer sequences for PCR analysis are HLA-G: 5 0 -CTGACCCTGACCGAGACCTGG-3 0 (forward) and 5 0 -GTCGCAGCCAATC ATCCACTGGAG-3 0 (reverse), and ADM2: 5 0 -AGGGAGGGGAACTCAGC AGTTCAGGAG-3 0 (forward) and 5 0 -GTTCTTGTTCTTGCTGTCAC TTGGGCCT-3 0 (reverse). The PCRs were performed using 1 ll of cDNA. Complementary DNA was mixed with Red Tag mix (Sigma). For 18S, 0.75 ll of primer pair (Ambion) was used according to the supplier's specifications. The PCRs for HLA-G and 18S were carried out in a GeneAmp PCR system 9700 (Perkin-Elmer, Norwalk, CT) with the following conditions: An initial denaturation step at 958C for 5 min was followed by 30 cycles of 30 sec at 948C, 30 sec at 558C, and 30 sec at 728C, and a final extension at 728C for 7 min. Total cycle number was chosen for each gene from the linear portion of its respective curves. The PCR product obtained was sequenced for its identity by DNA sequence analysis with forward and reverse gene-specific primers.
Quantitative Real-Time PCR
Real-time quantitative RT-PCR using SYBR Green (Bio-Rad, Hercules, CA) was performed with 1 ll of cDNA for HLA-G (forward primer: 5 0 -ctgaccctgaccgagacctgg-3 0 , and reverse primer: 5 0 -gtcgcagccaatcatccactggag-3 0 ). Amplification of 18S (forward primer: 5 0 -gctgagaagacggtcgaact-3 0 , and reverse: 5 0 -primerttaatgatccttccgcaggt-3 0 ) served as an endogenous control to standardize the amount of sample RNA added to a reaction. Reactions were incubated at 958C for 10 min and cycled according to the following parameters: 958C for 30 sec (melt) and 608C for 1 min (anneal/extend) for a total of 40 cycles. All experiments were performed in triplicates. Negative control and ''no-RT'' control reactions were performed. Negative controls were run in which the RNA templates were replaced by nuclease-free water in the reactions. For no-RT control, nuclease-free water was used in place of the reverse transcriptase.
Data were expressed as the ratio of the DNA amplification amount of 18S against that of the samples to avoid the error from the differences in sample ADM2 REGULATES HLA-G IN TROPHOBLAST CELLS processing and loading. The relative amount of every sample was calculated by use of C T 18S/C T sample; the higher value denoted the stronger mRNA expression. (The threshold cycle [C T ] value is the cycle at which a statistically significant increase in DRn [normalized reporter] is first detected.) The difference between groups was determined by one-way ANOVA. The significance level was set at P 0.05.
Electrophoresis and Gel Imaging
The PCR products were visualized on 1.4% agarose gels containing 0.5 lg/ ml ethidium bromide and run for 1.5 h at 100 V in 0.53 Tris-borateethylenediaminetetraacetic acid buffer. The DNA signals on the gel were imaged under ultraviolet light using a Polaroid camera (Photodyne Inc., New Berlin, WI). Negative controls were run in PCR using total RNA in place of cDNA, and no signal was detectable when run on agarose gel (data not shown).
NK Cell Culture
Peripheral blood mononuclear cells were isolated from the blood of healthy volunteers using a Ficoll gradient (Amersham Pharmacia Biotech, Uppsala, Sweden) and cultured (3 3 10 6 per milliliter) in RPMI 1640 medium (Sigma Chemical, St. Louis, MO) supplemented with 10% fetal calf serum (Gibco) for 72 h (5% CO 2 , 378C). NCAM1 MicroBeads (Miltenyi Biotech, Auburn, CA) were used for the positive selection of NK cells from human blood. NK-92 cells FIG. 1. Dual immunofluorescent colocalization of ADM2 with KRT7, HLA-G, and NCAM1 in first-trimester decidual tissue. A) Immunofluorescent colocalization of ADM2 (green) and KRT7 (red) in firsttrimester decidual tissue. Negative controls used are 1) staining without any primary antibody, 2) with rabbit preimmune serum, and 3) IgG. DAPI was used for blue nuclear staining. B) Immunofluorescent colocalization of ADM2 (green) and HLA-G (red) in first-trimester decidual tissue. Negative controls used are 1) staining without any primary antibody, 2) with rabbit preimmune serum, and 3) IgG. DAPI was used for blue nuclear staining. C) Immunofluorescent colocalization of ADM2 (green) and NCAM1 (red) in first-trimester decidual tissue. Negative controls used are 1) staining without any primary antibody, 2) with rabbit preimmune serum, and 3) IgG. DAPI was used for blue nuclear staining. Original magnifications 3400 (A and C) and 3200 (B).
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were obtained from American Type Culture Collection (Rockville, MD) and grown in alpha minimum essential medium supplemented with 12.5% fetal calf serum, 12.5% horse serum, 100 IU of interleukin 2, and 50 lM betamercaptoethanol, in a humidified incubator at 378C in 5% CO 2 . Blood NK cell and NK-92 cells (6 3 10 5 ) were harvested to isolate total RNA.
Phosphorylation Studies
For measurement of RAF1, MAP2K1/2, and MAPK3/1 phosphorylation, HTR-8SV/neo cells were treated with AMD2 (10 À8 M) in the presence or absence of U0126 (10 lM) or manumycin (10 lM), and with U0126 (10 lM) and manumycin (10 lM) alone. The cells were then incubated for 5 min at 378C in 5% CO 2 followed by the addition of lysis buffer containing 10% trichloroacetic acid and 1 mM ethylenediaminetetraacetic acid, and were transferred to À808C until use. Protein was estimated using bicinchoninic acid assay (Pierce Thermo Scientific, Rockford, IL) and used for Western blot analysis.
Western Immunoblotting
Protein lysate equivalent to 20 lg of the total protein was resolved on a 12% SDS-polyacrylamide gel and transferred to nitrocellulose membrane. The membrane was immunoblotted with b-tubulin (1:5000 dilution) or a 1:1000 dilution of HLA-G (Santa Cruz Biotechnology), pRAF1, RAF1, pMAP2K1/2, MAP2K1, pMAPK3/1, or total MAPK3/1 monoclonal antibody (Cell Signaling Technology, Boston, MA). Nitrocellulose membranes were then washed with Tris buffer saline containing 0.05% Tween-20 (TTBS) and incubated with 1:2000 dilution of anti-mouse antibody conjugated to horseradish peroxidase (Santa Cruz Biotechnology) in TTBS containing 5% nonfat dairy milk for 1 h. The membranes were then washed with TTBS and developed using the ECL system (Amersham, Piscataway, NJ). The blot was exposed to x-ray film and developed for visualization of protein bands. Protein bands were scanned to measure their density and analyzed using a Fluorchem Analysis System (Sigma Gel Software, San Leandro, CA). The protein levels are expressed as the ratio of the housekeeping protein b-tubulin, or total RAF1, MAP2K, or MAPK3/1 in the same blot.
Invasion Assay
Invasion assay was performed in a 96-well format of Matrigel-coated inserts (Trevigen Inc., Gaithersburg, MD). Inserts were seeded with HTR-8SV/ neo cells (15 000 cells per well) and treated with ADM2 (10 À8 M) in the presence or absence of U0126 (10 lM) and manumycin (10 lM), or U0126 and manumycin alone. The 96-well plate was then covered and incubated for 24 h at 378C followed by labeling of invaded cells with calcein AM and reading of the fluorescence at 494/517 nm as per the manufacturers' instructions.
Scratch Wound Assay for Migration
The first-trimester cytotrophoblast HTR-8SV/neo cells were cultured in RPMI 1640 containing 10% FBS in a humidified 5% CO 2 incubator at 378C. Cells were seeded in 24-well plates until confluence and were subsequently wounded by scratching with a pipette tip across the well according to the published protocol [25] . The cells were then washed with medium to remove the nonadherent cells, followed by the treatment with ADM2 (10 À8 
Data Analysis
Data are analyzed by one-way ANOVA followed by the Bonferroni t-test and are presented as mean 6 SEM. Unless specified, we used six replicates per group for the invasion assay and three replicates for RT-PCR analysis. All of the experiments were repeated at least three times. P 0.05 was taken as significant.
RESULTS

Localization of ADM2 Immunoreactivity in First-Trimester Decidual Tissue
Trophoblast invasion and migration occur through the decidual tissue, which is infiltrated with HLA-G-expressing invading cytotrophoblast cells and decidual natural killer (dNK) cells. In Figure 1 we demonstrate that ADM2 protein was colocalized with KRT7-positive extravillous cytotrophoblast cells, HLA-G-positive cytotrophoblast cells, and NCAM1-positive NK cells.
NK Cells Express ADM2 mRNA
Because ADM2-like immunoreactivity was present in NCAM1-positive NK cells in first-trimester decidual tissue, 
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we examined whether the ADM2 mRNA is expressed in peripheral blood NK cells and in NK-92 cells, which are widely used as an in vitro model for studying NK cell functions. Figure 2 demonstrates that ADM2 mRNA was expressed in both pNK as well as in NK-92 cells, suggesting a potential role for ADM2 in mediating the cellular response of NK cells. DNA sequence analysis of amplified PCR products showed 100% homology with the human ADM2 (data not shown).
Regulation of HLA-G Expression by ADM2 in Trophoblast Cells
We have previously reported that ADM2 increases the invasion and migration of trophoblast cells [3] . Because ADM2 expression was colocalized with HLA-G protein in this study (Fig. 1) , we assessed whether ADM2 regulates expression of HLA-G in trophoblast cells. As shown in Figure 3 , HTR-8SV/ neo cells treated with ADM2 showed a significant dosedependent increase in mRNA levels of HLA-G compared with the untreated cells, and further, these effects were abrogated in the presence of ADM2 , suggesting involvement of ADM2 in the regulation of HLA-G (P 0.05). We further assessed the effect of ADM2 treatment in the villous explants obtained from third-trimester placenta. As demonstrated in Figure 4 , ADM2 stimulated a ;2.2-fold increase in HLA-G mRNA as well as an increase in HLA-G protein expression in the treated villous explant cultures. HLA-G mRNA levels were increased with increasing doses of ADM2 peptide (P 0.05). However, unlike HTR-8SV/neo cells, these effects were not significantly abrogated by ADM2 17-47 treatment. Differential sensitivity of the explant culture to ADM2 17-47 may be due to the different cell type in third-trimester placental explants compared with first-trimester homogenous populations of HTR-8SV/neo cells.
Involvement of RAF1/MAPK3/1 Signaling Pathway in ADM2-Induced Invasion and Migration in HTR-8SV/neo Cells
To identify whether RAF1/MAPK3/1 transduction pathway is involved in ADM2-induced HTR-8SV/neo cell migration, we examined the effect of inhibitors of RAF1 and ERK activity on ADM2-induced trophoblast invasion and migration. We have previously shown that ADM2 stimulates invasive capacity of HTR-8SV/neo cells [3] . In this study we demonstrate in Figure 5A that ADM2-stimulated invasion of HTR-8SV/neo cells was inhibited in the presence of the inhibitors of ERK and RAF1 signaling molecules U0126 (10 lM) and manumycin (10 lM), respectively (P 0.05). Treatment of cells with U0126 and manumycin alone further inhibited the invasive capacity of HTR-8SV/neo cells compared with the controls. In Figure 5B , using scratch wound assay, we show that ADM2 (10 À8 M) treatment caused an increase in the migration of HTR-8SV/neo cells towards the cell-free area to fill the gap introduced by simulated wound. This increase in the migration of HTR-8SV/neo cells with ADM2 treatment was 3-fold compared with untreated cells, and this effect was inhibited when cells were treated with 
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RAF1 or MAPK3/1 inhibitors manumycin (10 lM) or U0126 (10 lM), respectively (P 0.05). Treatment of cells with U0126 and manumycin alone completely inhibited the migration of HTR-8SV/neo cells. Therefore, these results suggest involvement of MAPK3/1 signaling pathway in ADM2-stimulated invasion and migration of trophoblast cells.
Phosphorylation of RAF1, MAP2K1/2, and MAPK3/1 Proteins in HTR-8SV/neo Cells
To further confirm the involvement of MAPK3/1 signaling in ADM2-induced trophoblast cell migration, we assessed relative phosphorylation of RAF1, MAP2K, and MAPK3/1 proteins by treating the cells with ADM2 (10 À8 M) for 5 min in the presence or absence of manumycin (10 lM) or U0126 (10 lM). As shown in Figure 6 , ADM2 significantly increased (P 0.05) the relative amount of phosphorylated RAF1, MAP2K, and MAPK3/1 protein compared with the untreated cells, and ADM2-stimulated phosphorylation was inhibited in the presence of RAF1 and MAPK3/1 inhibitors. However, although significant, the magnitude of increase in RAF1 and MAP2K phosphorylation observed was only 10% compared with a 3-fold increase in MAPK3/1 phosphorylation. These data suggest that ADM2 actions are mediated through activation of MAPK3/1 signaling in trophoblast cells.
DISCUSSION
ADM2-related peptides CALCB and ADM are expressed in fetoplacental tissues and are reported to be important in maintaining normal placental function [26] [27] [28] [29] [30] . Deregulation of these peptides has been implicated in pathological pregnancies diagnosed with conditions such as hypertension and preeclampsia [26, 28, 31] . We have previously shown that ADM2 promotes fetoplacental growth in rats and increases the invasion and migration of HTR-8SV/neo cells [3] . In this study we show that the first-trimester decidual tissue possesses an intense ADM2-like immunoreactivity that colocalizes with HLA-G and NCAM1. In addition, we demonstrate that ADM2 is expressed in peripheral blood NK cells and in NK-92 cells, suggesting a possible autocrine/paracrine role of ADM2 in NK cell activity. The HLA-G molecule is exclusively expressed by invading EVTs in the first trimester and is reported to stimulate cytokine secretion in dNK cells at the maternal-fetal interface. This study demonstrates that ADM2 treatment dose dependently increases mRNA expression of HLA-G in HTR-8SV/ neo cells as well as in third-trimester placental explant cultures, suggesting that ADM2 expression in first-trimester placenta may mediate a cross talk between HLA-G-expressing cytotrophoblasts and cells that express receptors for HLA-G, such as dNK cells, at the maternal-fetal interface. Finally we demonstrate that ADM2 stimulates phosphorylation of MAPK signaling pathway protein in HTR-8SV/neo cells, indicating involvement of MAPK3/1 transduction pathway in ADM2-induced invasion and migration of HTR-8SV/neo cells. The present study is the first report on regulation of HLA-G antigen by ADM2 at the maternal-fetal interface in human pregnancy and involvement of MAPK3/1 signaling pathway in ADM2-stimulated trophoblast invasion and migration.
We have previously shown that ADM2 is expressed in placental trophoblast cells and that ADM2 increases invasion and migration of first-trimester HTR-8SV/neo cells [3] . In this study we assessed immunolocalization of ADM2 in firsttrimester decidual tissue obtained from women undergoing elective abortions. Colocalization of ADM2-like immunoreactivity with HLA-G-positive cytotrophoblast and dNK cells as 
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shown in Figure 1 suggests that ADM2 may be involved in the regulation of HLA-G in trophoblasts and in regulating some aspect of dNK cell function. Because ADM2 protein colocalizes with NCAM1-positive cells, we further identified whether ADM2 mRNA is expressed in peripheral blood pNK cells and NK-92 cells, which are commonly used as an in vitro model for studying NK cell function. Figure 2 demonstrates that ADM2 transcript is expressed in pNK cells as well as in NK-92 cells, suggesting that ADM2 may have an autocrine/ paracrine role in dNK cell function. Expression of HLA-G is reported to increase in the EVTs as they migrate into the decidua and towards the vasculature [17] . Because ADM2 increases invasion and migration of cytotrophoblast cells [3] and HLA-G immunoreactivity was found to be colocalized with ADM2 in decidual tissue, we assessed whether ADM2 is involved in the regulation of HLA-G. In Figure 3 we show that ADM2 increases the expression of HLA-G mRNA in HTR-8SV/neo cells in a dose-dependent manner, and these effects are nullified in the presence of ADM2 antagonist (P 0.05). Because of the difficulty in obtaining decidual tissue from firsttrimester elective abortions, we used villous explant cultures of placenta obtained from third-trimester pregnancy to study the effect of ADM2 on HLA-G expression on villous trophoblasts. However, as shown in Figure 4 , ADM2 increases the expression of HLA-G mRNA (Fig. 4A) and protein (Fig. 4B ) in term placental explant culture, but the effects of ADM2 are not reversed by ADM2 antagonist. The discrepancy in the response of villous explants to ADM2 17-47 on ADM2-induced HLA-G expression could be attributed to the sample type being the term placental explants. HTR-8SV/neo cells are a pure population of first-trimester cytotrophoblast cells, whereas third-trimester villous explant culture constitutes a mixed population of different types of cells that may respond to ADM2 with different sensitivity.
Regulation of HLA-G by ADM2 in trophoblast cells suggests that the invasive effect of ADM2 may involve a cross talk between the HLA-G-expressing trophoblast cells and other cell types at the maternal-fetal interface that express the receptors for HLA-G. The functions of HLA-G are due to their ability to act as a ligand for different receptors expressed by immune cells, such as T and B lymphocytes, monocytes/ macrophages, and dNK cells [32, 33] . In Figures 1 and 2 we have shown that ADM2 mRNA as well as protein is expressed in NK cells, suggesting an autocrine/paracrine role for ADM2 in NK cell function, which may involve regulating HLA-G receptors expressed on dNK cells and stimulating growth factors and/or cytokines to promote vasculogenesis and angiogenesis in early placental development.
MAPK3/1 signaling pathways are reported to be involved in the invasion and migration of numerous cell types. In this study we assessed whether MAPK pathway signaling molecules control ADM2 invasive and migratory effects in HTR-8SV/neo cells. Figure 5 shows that in the presence of inhibitors of RAF1 and MAPK3/1, the stimulatory effects of ADM2 on invasion and migration of HTR-8SV/neo cells are inhibited. Further, to confirm these effects we assessed the effect of ADM2 treatment on the relative phosphorylation of MAPK signaling pathway proteins in HTR-8SV/neo cells. ADM2 stimulates a 3-fold increase in phosphorylation of MAPK3/1 protein compared with a 10% stimulation in pRAF1 and pMAP2K (Fig. 6) , suggesting that the MAPK signaling pathway is involved in ADM2 effects in trophoblast cells.
In summary, ADM2 is localized in decidual HLA-Gexpressing cytotrophoblast cells and NK cells, and it regulates expression of HLA-G in trophoblast cells. Further ADM2-induced trophoblast cell invasion and migration are mediated through MAPK signaling pathway. Although preliminary, the present study suggests a novel regulator of HLA-G at the 
